Vyant Bio (VYNT) Financials

$0.19

$0.02 (9.30%)

As on 29-Dec-2023 15:40EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.20	0.67	1.15	0.87	7.31	27.47
Cost of Revenue	0.32	1.01	1.85	1.10	3.70	18.72
Gross Profit	-0.12	-0.34	-0.70	-0.23	3.60	8.75
Operating Expenses	7.06	15.57	12.70	5.95	6.32	26.94
Operating Profit (EBIT)	-7.18	-15.91	-15.71	-7.62	-2.71	-18.19
Other Income	--	--	--	--	--	--
Profit before Tax	-7.08	-15.81	-18.58	-8.65	-7.40	-20.37
Provision for Tax	6.67	6.88	27.52	0.55	-0.51	-0.06
Profit after Tax (Net Income)	-13.74	-22.69	-46.10	-9.20	-6.71	-20.37
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-14.05	--	-40.86	-8.65	-8.96	-8.45

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	--	9.91	31.29	-36.44	7.39	6.80
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	1.63	0.92	38.44	0.55	1.31
Current Liabilities	1.20	3.67	5.43	2.05	6.97	27.29
Total Liabilities	1.20	15.21	37.64	4.05	14.90	35.41

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	--	3.70	14.42	2.26	7.73	26.06
Current Assets	3.43	11.51	23.21	1.79	7.18	9.35
Total Assets	3.43	15.21	37.64	4.05	14.90	35.41
Total Debt*	--	2.20	1.20	7.95	1.66	11.81
Net Current Assets	--	7.84	17.78	-0.26	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-13.68	-16.99	-5.81	-8.66	-12.55
Cash Flow from Investing Activities	--	--	29.62	-0.04	-0.39	-0.73
Cash from Financing Activities	--	-0.15	7.19	6.33	3.31	2.15
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	-3.87	-7.95	-1.59	-3.19	-12.49
Cash EPS ($)	--	-3.72	-7.77	-1.39	-3.19	-12.49
Adjusted Book Value ($)	--	1.69	5.40	--	3.51	4.17
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.33	-2.93	-1.00	-4.11	-7.70
Free Cash Flow per Share ($)	--	-2.44	-3.02	-1.01	-4.13	-8.11

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-101.77	-2,305.33	94.57	-48.52	-72.23
ROE (%)	--	-110.15	1,790.10	63.30	-94.57	-121.39
ROA (%)	-72.80	-85.88	-221.16	-97.04	-26.67	-46.50
EBIT Margin (%)	-6,688.38	-2,389.19	-1,368.12	-879.24	-79.16	-66.45
Net Margin (%)	-6,939.90	-3,406.91	-4,015.24	-1,060.67	-91.83	-74.16
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	135.80	-0.42	0.32	-0.88	-0.73	-0.06
EBIT Growth (%)	15.42	-1.31	-106.03	-31.82	68.32	12.38
Net Profit Growth (%)	68.96	50.78	-401.25	-37.09	67.07	2.43
EPS Growth (%)	--	0.51	-4.01	0.50	0.74	0.46
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.18	-0.17	-1.75	-1.87	-0.02
Price / Book Value	0.12	0.41	0.25	-0.44	1.70	0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.44	0.25	1.55	-4.59	-2.05	-0.75
Close Price ($)	0.20	0.70	6.75	13.85	29.80	36.30
High Price ($)	4.60	9.85	87.50	51.95	67.50	330.00
Low Price ($)	0.18	0.66	6.50	9.60	10.02	30.00
Market Cap ($ Cr)	1.23	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.22	0.04	-0.22	0.22	1.74
Short term debt to equity ratio	--	0.06	0.01	-0.01	0.17	0.36
Current Ratio	2.86	3.14	4.27	0.87	1.03	0.34
Quick Ratio	2.86	3.13	4.19	0.67	0.98	0.29
Interest Coverage	-75.09	-171.10	-42.22	-14.25	-4.02	-8.61

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	118.18	48.50	37.80	44.87	21.68	25.62
Asset Turnover	0.01	0.03	0.06	0.09	0.29	0.63
Receivable days	--	207.58	130.92	415.59	215.55	119.64
Inventory Days	--	95.66	88.00	130.54	89.31	31.91
Payable days	--	252.74	201.71	285.63	28.18	2.91
Cash Conversion Cycle	--	50.50	17.22	260.50	276.69	148.65

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.